E. James Levine - Sep 16, 2022 Form 4 Insider Report for Cardiff Oncology, Inc. (CRDF)

Role
Chief Financial Officer
Signature
/s/ James Levine
Stock symbol
CRDF
Transactions as of
Sep 16, 2022
Transactions value $
$46,710
Form type
4
Date filed
9/19/2022, 08:37 AM
Previous filing
Mar 10, 2022
Next filing
Mar 16, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CRDF Common Stock Purchase $46.7K +30K +100% $1.56 60K Sep 16, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.555 to $1.56. Full information regarding the number of shares purcahsed at each separate price can be furnished to the SEC staff upon request.